Abstract
The culture supernatant of B cells from patients with active systemic lupus erythematosus (SLE) who had never been treated with corticosteroids had bone-resorbing activity (BRA) which stimulated the45Ca release from prelabeled murine fetal bones. Then we studied the characteristics and the relationship of this BRA with several lymphokines previously reported. The BRA was eluted as three peaks at approximately 17,000, 35,000, and 80,000 daltons by Sephacryl S-200 column chromatography. Recombinant (r)IL 1α, rIL 1β, and rTNF possessed BRA, but rIL 4 and rIL 6 did not. Furthermore, the BRA from SLE B cells was absorbed with anti-IL 1α antibody but not with anti-IL 1β and anti-TNF antibody. Therefore, the fact that SLE B cells produce BRA which corresponds to IL 1α and IL 1α produced by B cells might be one of the causes of bone destruction in SLE patients.
Similar content being viewed by others
References
Horton JE, Raisz LG, Simmons HA, Oppenheim JJ, Mergenhagen SE: Bone resorbing activity in supernatant fluid from cultured human peripheral blood leukocytes. Science 177:793–795, 1972
Smith HR, Steinberg AD: Autoimmunity-A perspective. Annu Rev Immunol 1:175–210, 1983
Steinberg AD, Raveche ES, Laskin CA, Smith HR, Sontoro T, Miller ML, Plotz PH: Systemic lupus erythematosus: Insights from animal model. Ann Intern Med 100:714–727, 1984
Dubois LE, Cozen L: A vascular (aseptic) bone necrosis associated with systemic lupus erythematosus. JAMA 174:966–971, 1960
Smith SE, Sweet DE, Brunner CM, Davis JS: A vascular: necrosis in SLE: An apparent predilection for young patients. Ann Rheum Dis 35:227–232, 1976
Siemsen JK, Brook J, Meister L: Lupus erythematosus and avascular bone necrosis: A clinical study of three cases and review of the literature. Arth Rheum 5:492–501, 1962
Nilsen KH: Systemic lupus erythematosus and avascular bone necrosis. NZ Med J 85:472–475, 1977
Wilde AH, Mankin HJ, Rodman GP: Avascular necrosis of the femoral head in scleroderma. Arch Rheum 13:445–447, 1970
Zizic TM, Hungerford DS, Stevens MB: Ischemic bone necrosis in systemic lupus erythematosus. I. The early diagnosis of ischemic necrosis of bone. Medicine 59:134–142, 1980
Klipper AR, Stevens MB, Zizic TM, Hungerford DS: Ischemic necrosis of bone in systemic lupus erythematosus. Medicine 55:251–257, 1976
Labowitz R, Schumacher HR Jr: Articular manifestations of systemic lupus erythematosus. Ann Intern Med 74:911–921, 1971
Brookes M, Helal B: Primary osteoarthritis, venous engorgement and osteogenesis. J Bone Joint Surgery 50B:493–504, 1968
Tanaka Y, Shirakawa F, Ota U, Suzuki H, Eto S, Yamashita U: Mechanism of spontaneous activation of B cells in patients with systemic lupus erythematosus: Analysis with anti-class II antibody. J Immunol 140:761–767, 1988
Tanaka Y, Saito K, Shirakawa F, Suzuki H, Eto S, Yamashita U: Production of B cell stimulating factors by B cells in patients with systemic lupus erythematosus. J Immunol 141:3043–3049, 1988
Gowen M, Wood DD, Ihrie EJ, McGuire MKB, Russell RGG: An interleukin I like factor stimulates bone resorptionin vitro. Nature 306:378–380, 1983
Stashenko P, Dewhirst FE, Peros WJ, Kent RL, Ago JM: Synergistic interactions between interleukin 1, tumor necrosis factor, and lymphotoxin in bone resorption. J Immunol 138:1464–1468, 1987
Dewhrist FE, Stashenko PP, Mole JE, Tsurumachi T: Purification and partial sequence of human osteoclast-activating factor: Identity with interleukin 1β. J Immunol 135:2562–2568, 1985
Sato K, Mimura H, Han DC, Kakiuchi T, Ueyama Y, Ohkawa H, Okabe T, Kondo Y, Ohsawa N, Tsushima T, Shizume K: Production of bone-resorbing activity and colony-stimulating activityin vivo andin vitro by a human squamous cell carcinoma associated with hypercalcemia and leukocytosis. J Clin Invest 78:145–154, 1986
Tan EM, Cohen AS, Fries J, Masi AT, McShane OJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria of the classification of systemic lupus erythematosus. Arth Rheum 25:1271–1277, 1982
Budman DR, Merchant EB, Steinberg AD, Doft B, Gershwin ME, Lizzio E, Reeves JP: Increased spontaneous activity of antibody-forming cells in the peripheral blood of patients with active SLE. Arth Rheum 20:829–833, 1977
Furutani Y, Notake M, Yamayoshi M, Yamagishi R, Fukui T, Yamada M, Nakamura S: Cloning for and characterization of the cDNA for human and rabbit interleukin 1 precursor. Nucleic Acids Res 13:5869–5882, 1985
Nishida T, Nishino N, Takano M, Kawai K, Bando K, Masui Y, Nakai S, Hirai Y: cDNA cloning of IL 1α and IL 1β from mRNA of U937 cell line. Biochem Biophys Res Commun 143:345–352, 1987
Severinson E, Naito T, Tokumoto H, Fukushima D, Hirano A, Hama K, Honjo T: Interleukin 4 (IgG1 induction factor): A multifunctional lymphokine acting also on T cells. Eur J Immunol 17:67–72, 1987
Hirano T, Yasukawa K, Harada H, Taga T, Watanabe Y, Matsuda T, Kashiwamura S, Nakajima K, Iwamatsu A, Tsunasawa S, Sakiyama F, Matsui H, Takahara Y, Taniguchi T, Kishimoto T: Complementary DNA for a novel human interleukin 6 (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 324:73–76, 1986
Hirano T, Taga T, Yasukawa K, Nakajima K, Nakao N, Takatsuki F, Shimizu M, Murashima A, Tsunasawa S, Sakiyama F, Kishimoto T: Human B cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production. Proc Natl Acad Sci USA 84:228–231, 1987
Shirai T, Yamaguchi H, Ito H, Todd CW, Wallace RB: Cloning and expression inEscherichia coli of the gene for human tumor necrosis factor. Nature 313:803–806, 1985
Niitsu Y, Watanabe N, Sone H, Neda H, Yamaguchi N, Urushizaki I: Mechanism of the cytotoxic effect of tumor necrosis factor. Jpn J Cancer Res (Gann) 76:1193–1197, 1985
Yamashita U, Shirakawa F, Nakamura H: Production of interleukin 1 by adult T cell leukemia (ATL) cell lines. J Immunol 138:3284–3289, 1987
Shirakawa F, Yamashita U, Tanaka Y, Watanabe K, Sato K, Haratake J, Fujihira T, Oda S, Eto S: Production of bone-resorbing activity corresponding to interleukin-1α by adult T-cell leukemia cells in humans. Cancer Res 48:4264–4287, 1988
Raisz LG: Bone resorption in tissue culture: Factors influencing the response to parathyroid hormone. J Clin Invest 44:103–116, 1965
Ruff MR, Gifford GE: Purification and physico-chemical characterization of rabbit tumor necrosis factor. J Immunol 125:1671–1677, 1980
Yokota T, Otsuka T, Mosmann T, Banchereau J, Defrance T, Blanchard D, de Vries J, Lee F, Arai K: Isolation and characterization of a human interleukin cDNA clone, homologous to mouse BSF-1, which expresses B cell and T cell stimulating activities. Proc Natl Acad Sci USA 83:5894–5898, 1986
Chen P, Trummel C, Horton J, Baker JJ, Oppenheim JJ: Production of osteoclast-activating factor by normal human peripheral blood rosetting and nonrosetting lymphocytes. Eur J Immunol 6:732–736, 1976
Yoneda T, Mundy GR: Prostaglandins are necessary for osteoclast activating factor production by activated peripheral blood leukocytes. J Exp Med 149:279–283, 1979
Luben RA: Purification of a lymphokine: Osteoclast activating factor from human tonsil lymphocytes. Biochem Biophys Res Commun 84:15–22, 1978
Mundy GR, Luben RA, Raisz LG, Oppenheim JJ, Buell DN: Bone-resorbing activity in supernatants from lymphoid cell lines. N Engl J Med 290:867–871, 1974
Scala G, Kuang YD, Hall RE, Muchmore AV, Oppenheim JJ: Accessory cell function of human B cells. I. Production of both interleukin 1-like activity and an interleukin 1 inhibitory factor by an EBV-transformed human B cell line. J Exp Med 139:1637–1652, 1984
Matsushima K, Antonio P, Abe H, Scala G, Ortaldo JR, Oppenheim JJ: Production of interleukin 1 activity by normal human peripheral blood B lymphocytes. J Immunol 135:1132–1136, 1985
Gray PW, Glaister D, Chen E, Goeddel DV, Pennica D: Two interleukin 1 gene in the mouse: Cloning and expression of the cDNA for murine interleukin 1β. J Immunol 137:3644–3648, 1986
March CJ, Mosley B, Larson A, Carretti DP, Braedt G, Price V, Gillis S, Henney CS, Kronheim SR, Grabstein K, Conlon PJ, Hopp TP, Cosmon D: Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature 315:641–647, 1985
Shirakawa F, Yamashita U, Suzuki H: Decrease in HLA-DR-positive monocytes in patients with systemic lupus erythematosus (SLE). J Immunol 134:3560–3562, 1985
Shirakawa F, Yamashita U, Suzuki H: Reduced function of HLA-DR-positive monocytes in patients with systemic lupus erythematosus (SLE). J Clin Immunol 5:396–403, 1985
Sato K, Fujii Y, Kasano K, Saji M, Tsushima T, Shizume K: Stimulation of prostaglandin E2 and bone resorption by recombinant human interleukin 1 alpha in fetal mouse bones. Biochem Biophys Res Commun 138:618–624, 1986
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tanaka, Y., Watanabe, K., Suzuki, M. et al. Spontaneous production of bone-resorbing lymphokines by B cells in patients with systemic lupus erythematosus. J Clin Immunol 9, 415–420 (1989). https://doi.org/10.1007/BF00917107
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00917107